Yonatan Malca is Director at Entera Bio Ltd. (ENTX). They have made 1 open-market trade across 1 company since 2022, most recently 2026-08-07.
CIK 0001904759
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $20K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ENTX | 100,231 | $269K |
Shares reported on the most recent Form 4, priced at the 2026-08-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENTX | BUY | 2022-01-13 | 2022-01-18 | $2.74 | $20K | -22.0% | -25.9% | -1.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.